Cargando…
Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system
BACKGROUND: In the Veterans Health Administration, patiromer is a formulary medication restricted by prior authorization and criteria-for-use (CFU). Historically, patiromer approval was restricted by step therapy, requiring prescribers to trial sodium polystyrene sulfonate (SPS). OBJECTIVE: To descr...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372981/ https://www.ncbi.nlm.nih.gov/pubmed/36427342 http://dx.doi.org/10.18553/jmcp.2022.28.12.1410 |